Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules

Completed · Phase 1

Conditions studied: Healthy

In brief

Commercial ziprasidone capsules show a large increase in bioavailability with food. The formulation tested in this study aims to reduce or eliminate that increase.

Key facts

Study ID

NCT00821444

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

11

Starts

2009-01-01

Expected to finish

2009-03-01

Last updated by the study team

2021-02-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy subjects
• Signed informed consent document

You may not qualify if…

• Any significant physical or psychological disease
• Concomitant administration of other pharmaceuticals

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.